Galena Biopharma (Nasdaq: GALE) announced the Notice of Allowance of a U.S. patent application covering methods of treating patients having ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE